-
1
-
-
0034771749
-
Patient adherence to treatment: Three decades of research. A comprehensive review
-
Vermeire E, Hearnshaw H, Van Royen P, et al.: Patient adherence to treatment: Three decades of research. A comprehensive review. J Clin Pharm Ther. 2001; 26: 331-342.
-
(2001)
J Clin Pharm Ther
, vol.26
, pp. 331-342
-
-
Vermeire, E.1
Hearnshaw, H.2
Van Royen, P.3
-
2
-
-
77951102841
-
Primary medication non-adherence: Analysis of 195,930 electronic prescriptions
-
Fischer MA, Stedman MR, Lii J, et al.: Primary medication non-adherence: Analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010; 25(4): 284-290.
-
(2010)
J Gen Intern Med
, vol.25
, Issue.4
, pp. 284-290
-
-
Fischer, M.A.1
Stedman, M.R.2
Lii, J.3
-
3
-
-
51349156689
-
Unfilled prescriptions of medicare beneficiaries: Prevalence, reasons, and types of medicines prescribed
-
Kennedy J, Tuleu I, Mackay K: Unfilled prescriptions of medicare beneficiaries: Prevalence, reasons, and types of medicines prescribed. J Manag Care Pharm. 2008; 14(6): 553-560.
-
(2008)
J Manag Care Pharm
, vol.14
, Issue.6
, pp. 553-560
-
-
Kennedy, J.1
Tuleu, I.2
Mackay, K.3
-
4
-
-
9444280220
-
Patterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: A prospective, observational study
-
Manchikanti L, Damron KS, McManus CD, et al.: Patterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: A prospective, observational study. Pain Physician. 2004; 7(4): 431-437. (Pubitemid 39562100)
-
(2004)
Pain Physician
, vol.7
, Issue.4
, pp. 431-437
-
-
Manchikanti, L.1
Damron, K.S.2
McManus, C.D.3
Barnhill, R.C.4
-
5
-
-
55249087042
-
The use of urine drug testing to monitor patients receiving chronic opioid therapy for persistent pain conditions
-
282
-
Tellioglu T: The use of urine drug testing to monitor patients receiving chronic opioid therapy for persistent pain conditions. Med Health R I 2008; 91(9): 279-280, 282.
-
(2008)
Med Health R I
, vol.91
, Issue.9
, pp. 279-280
-
-
Tellioglu, T.1
-
6
-
-
69249143742
-
2009 Clinical Guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: What are the key messages for clinical practice?
-
Chou R: 2009 Clinical Guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: What are the key messages for clinical practice? Pol Arch Med Wewn. 2009; 119(7-8): 469-477.
-
(2009)
Pol Arch Med Wewn
, vol.119
, Issue.7-8
, pp. 469-477
-
-
Chou, R.1
-
7
-
-
43649102347
-
Opioids in the management of chronic non-cancer pain: An update of American Society of Interventional Pain Physicians' (ASIPP) Guidelines
-
Trescot AM, Helm S, Hansen H, et al.: Opioids in the management of chronic non-cancer pain: An update of American Society of Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician. 2008; 11: S5-S62.
-
(2008)
Pain Physician
, vol.11
-
-
Trescot, A.M.1
Helm, S.2
Hansen, H.3
-
8
-
-
68949220857
-
High rates of inappropriate drug use in the chronic pain population
-
Couto J, Romney M, Leider H, et al.: High rates of inappropriate drug use in the chronic pain population. Popul Health Manag. 2009; 12(4): 185-190.
-
(2009)
Popul Health Manag
, vol.12
, Issue.4
, pp. 185-190
-
-
Couto, J.1
Romney, M.2
Leider, H.3
-
9
-
-
76149121495
-
Comparison of clonazepam compliance by measurement of urinary concentration by immunoassay and LC-MS/MS in a pain management population
-
West R, Pesce A, West C, et al.: Comparison of clonazepam compliance by measurement of urinary concentration by immunoassay and LC-MS/MS in a pain management population. Pain Physician. 2010; 13: 71-78.
-
(2010)
Pain Physician
, vol.13
, pp. 71-78
-
-
West, R.1
Pesce, A.2
West, C.3
-
10
-
-
73849147583
-
LC-MS/MS extends the range of drug analysis in pain patients
-
Mikel C, Almazan P, West R, et al.: LC-MS/MS extends the range of drug analysis in pain patients. Ther Drug Monit. 2009; 31: 746-748.
-
(2009)
Ther Drug Monit
, vol.31
, pp. 746-748
-
-
Mikel, C.1
Almazan, P.2
West, R.3
-
12
-
-
77957324728
-
-
Agilent Corp.: Agilent Technologies, Inc. [MSD ChemStation Data Analysis] Last Reviewed: March 20
-
Agilent Corp.: Target Compound Identification and Quantitation Procedure. Agilent Technologies, Inc. [MSD ChemStation Data Analysis] Last Reviewed: March 20, 2002.
-
(2002)
Target Compound Identification and Quantitation Procedure
-
-
-
13
-
-
73849126333
-
6-Acetylmorphine detected in the absence of morphine in pain management patients
-
Crews B, Mikel C, Latyshev S, et al.: 6-Acetylmorphine detected in the absence of morphine in pain management patients. Ther Drug Monit. 2009; 31: 749-752.
-
(2009)
Ther Drug Monit
, vol.31
, pp. 749-752
-
-
Crews, B.1
Mikel, C.2
Latyshev, S.3
-
14
-
-
77949520064
-
Variability of transdermal fentanyl metabolism and excretion in pain patients
-
Cole JM, Best BM, Pesce AJ: Variability of transdermal fentanyl metabolism and excretion in pain patients. J Opioid Manag. 2010; 6(1): 29-39.
-
(2010)
J Opioid Manag
, vol.6
, Issue.1
, pp. 29-39
-
-
Cole, J.M.1
Best, B.M.2
Pesce, A.J.3
-
15
-
-
76149101189
-
Effective monitoring of opiates in chronic pain patients
-
Evans M, Kriger S, Gunn J, et al.: Effective monitoring of opiates in chronic pain patients. Tract Pain Manag. 2009: 9: 32-33.
-
(2009)
Tract Pain Manag
, vol.9
, pp. 32-33
-
-
Evans, M.1
Kriger, S.2
Gunn, J.3
|